Safety Alerts & Recalls

Search all Safety Alerts & Recalls

Latest Alerts

Glycopyrrolate: Corepharma LLC Issues Recall
Corepharma LLC is recalling several lots of Glycopyrrolate 1 mg and 2 mg tablets because the following lots may not pass the manufacturer's routine tests for impurities: 1) Glycopyrrolate Tablets, 1 mg - Lot numbers CPA964, 100991, and 101560 2) Glycopyrrolate Tablets, 2 mg - Lot numbers CPL7117, CPE854, CPF878, CPL823, CPA965, CPA966, 101039, and 101540 Glycopyrrolate is used in combination with other medications to treat ulcers. It is also used for excessive sweating, heartburn, irritable bowel disease, and ulcerative colitis. Glycopyrrolate is also sold under the brand name Robinul. This recall alert only applies to the above lots of generic Glycopyrrolate 1 mg and 2 mg tablets made by Corepharma, LLC. No other glycopyrrolate products are involved in this recall. To view the FDA notice about this recall, please visit: http://www.fda.gov/Safety/Recalls/EnforcementReports/ucm208729.htm
Learn More

Apotex Recalls One Lot of Fluticasone Nasal Spray
Apotex, Inc. is recalling a single lot of Fluticasone Propionate Nasal Spray, 50 mcg per spray, 16 g, 120 Metered Sprays per bottle. Lot JJ7064 is being recalled because bottles in this lot may be contaminated with metal fragments. Fluticasone Propionate Nasal Spray is used in the management of nasal symptoms of allergic and nonallergic rhinitis. Fluticasone nasal spray is also sold under the brand name Flonase and Veramyst. Other formulations of fluticasone are used to treat lung conditions, including asthma and chronic obstructive pulmonary disease (COPD). This recall alert only applies to the single lot of the generic Fluticasone Propionate Nasal Spray made by Apotex. No other fluticasone products were involved in this recall. To view the FDA notice about this recall, please visit: http://www.fda.gov/Safety/Recalls/EnforcementReports/ucm208729.htm
Learn More

Date Published Title Drug Source
2010-04-20 Glycopyrrolate: Corepharma LLC Issues Recall Glycopyrrolate FDA
2010-04-20 Apotex Recalls One Lot of Fluticasone Nasal Spray Fluticasone Nasal FDA
2010-04-20 Apotex Recalls Two Lots of Ipratropium Nasal Solution Ipratropium FDA
2010-04-15 Asthma and COPD Inhalers That Contain Ozone-depleting CFCs to be Phased Out; Alternative Treatments Available Maxair FDA
2010-04-15 Asthma and COPD Inhalers That Contain Ozone-depleting CFCs to be Phased Out; Alternative Treatments Available Albuterol Sulfate with Ipratropium Bromide FDA
2010-04-15 Asthma and COPD Inhalers That Contain Ozone-depleting CFCs to be Phased Out; Alternative Treatments Available Flunisolide Inhalation FDA
2010-04-15 Asthma and COPD Inhalers That Contain Ozone-depleting CFCs to be Phased Out; Alternative Treatments Available Cromolyn Sodium FDA
2010-04-15 Asthma and COPD Inhalers That Contain Ozone-depleting CFCs to be Phased Out; Alternative Treatments Available Triamcinolone Inhalation FDA
2010-04-15 Asthma and COPD Inhalers That Contain Ozone-depleting CFCs to be Phased Out; Alternative Treatments Available Metaproterenol FDA
2010-04-15 Asthma and COPD Inhalers That Contain Ozone-depleting CFCs to be Phased Out; Alternative Treatments Available Nedocromil FDA
2010-04-13 Voluntary Recall of Several Zyrtec Products Cetirizine Manufacturer
2010-04-13 Voluntary Recall of Several Infants' Motrin Products Ibuprofen Manufacturer
2010-04-13 Voluntary Recall of Several Children's Tylenol and Infants' Tylenol Products Acetaminophen Manufacturer
2010-04-13 Voluntary Recall of Certain Lots of Claritin Eye Drops Loratadine Manufacturer
2010-04-13 Oftalmi Announces Recall of the Camolyn Eye Drops Product Line Naphazoline FDA
2010-04-13 FDA Updates Healthcare Professionals on Suspension of Use of Rotarix Vaccine Rotavirus Vaccine FDA
2010-04-13 Recall of Select Lots of Selenium Sulfide Shampoo, 2.25% Selenium FDA
2010-04-13 Select Lots of Clearasil Ultra Recalled Because Lot Code Can Be Removed Benzoyl Peroxide FDA
2010-04-12 Aton Pharma, Inc. Recalls All Supplies of Demser capsules, 250 mg Metyrosine FDA
2010-04-12 Recall of Select Lots of Rosaderm Cleanser FDA
Back to Consumer Med Safety